SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-010429
Filing Date
2019-04-01
Accepted
2019-04-01 16:18:53
Documents
108
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alt-10k_20181231.htm 10-K 4052567
2 EX-21 alt-ex21_12.htm EX-21 4568
3 EX-23.1 alt-ex231_10.htm EX-23.1 10760
4 EX-31.1 alt-ex311_9.htm EX-31.1 18838
5 EX-31.2 alt-ex312_8.htm EX-31.2 18579
6 EX-32.1 alt-ex321_6.htm EX-32.1 6069
7 EX-32.2 alt-ex322_7.htm EX-32.2 6112
  Complete submission text file 0001564590-19-010429.txt   13889422

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alt-20181231.xml EX-101.INS 2731661
9 XBRL TAXONOMY EXTENSION SCHEMA alt-20181231.xsd EX-101.SCH 95469
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20181231_cal.xml EX-101.CAL 89294
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20181231_def.xml EX-101.DEF 455106
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20181231_lab.xml EX-101.LAB 773444
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20181231_pre.xml EX-101.PRE 667313
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32587 | Film No.: 19720938
SIC: 2834 Pharmaceutical Preparations